Several are already FDA-approved, including Semaglutide, Tirzepatide, Tesamorelin, Sermorelin and a handful of others. Dozens more - including BPC-157, GHK-Cu analogs, and various GH secretagogues - are in various stages of clinical investigation.

In short: Published peptide research clusters around tissue repair, metabolic signalling, growth-hormone axes, skin biology, cognition and immune pathways. Some compounds are FDA-approved medicines. Many others remain investigational or research-only. Evidence quality varies by compound. This page summarises research themes, not treatment advice. Research use only.

Key facts

Claims should map to a named compound, receptor pathway and published study design.

Approved examples (for example semaglutide, tirzepatide) differ from research reagents.

Preclinical tissue-repair peptides (for example BPC-157) are not the same evidence class as Phase 3 incretins.

Mechanism language is stronger than guaranteed outcome language.

New-U products are research use only, not for human consumption.

Claims about recovery, body composition, sleep, skin or cognition should map to a specific compound, receptor and published evidence. This article walks through major research categories, mechanisms and study context.

Several peptides are FDA-approved medicines. Dozens more sit in Phase II or Phase III programmes. That does not make every research peptide a medicine. Evidence strength differs by compound and study design. For chemistry context, see amino acids vs peptides. For publication volume, see the most-researched peptides of 2026.

1. Tissue Repair & Injury Recovery

Key compounds: BPC-157, TB-500 (Thymosin Beta-4), GHK-Cu.

Mechanism: These peptides upregulate angiogenesis (new blood-vessel formation), stimulate growth factors VEGF and FGF, and recruit stem cells to sites of tissue damage. BPC-157 has been shown to accelerate tendon-to-bone healing, protect the gastrointestinal mucosa, and reduce inflammation at injury sites in over thirty animal studies published across the 1990s and 2000s.

Research associations: tendon, ligament and muscle repair models; inflammation markers; gut-mucosa protection in preclinical work. Popular culture often overstates certainty. Treat athlete anecdotes as anecdotes, not as clinical proof.

BPC-157, Body Protective Compound 157. A 15-amino-acid sequence derived from human gastric juice. Originally identified for gastroprotective effects. Later research documented systemic tissue-repair activity across tendon, ligament, nerve and muscle models.

2. Metabolic Regulation & Fat Loss

Key compounds: Semaglutide, Tirzepatide, Tesamorelin, HGH Fragment 176-191.

Mechanism: GLP-1 receptor agonists slow gastric emptying and suppress appetite at the hypothalamic level. Dual GIP/GLP-1 agonists add an incretin pathway that further improves insulin sensitivity. Tesamorelin is a GHRH analog that selectively reduces visceral adipose tissue.

Evidence notes: licensed GLP-1 and dual agonists have large Phase III programmes measuring weight, glycaemia and related endpoints. Research-grade material is a separate category and is not a substitute for approved medicines.

3. Growth-Hormone Optimisation & Sleep

Key compounds: CJC-1295, Ipamorelin, Sermorelin, MK-677.

Mechanism: These peptides stimulate the pituitary to release growth hormone in a pulsatile fashion, mimicking the natural rhythm of a young adult, rather than the flat exogenous GH injections used in old-school protocols. CJC-1295 extends GH half-life. Ipamorelin adds a clean ghrelin-receptor pulse with no cortisol spike and no appetite stimulation.

Research associations: sleep architecture, body-composition markers and recovery endpoints appear in growth-hormone secretagogue literature. Age-related GH decline is well documented. Pulsatile stimulation is studied as a research strategy, not as consumer advice here.

4. Skin, Hair & Collagen Remodelling

Key compounds: GHK-Cu, Epitalon, Copper peptides.

Mechanism: GHK-Cu, a copper-binding tripeptide, was shown in a 2012 Broad Institute study to modulate expression of 4,382 human genes . It upregulates collagen types I, III and V, elastin, decorin, antioxidant defenses, and anti-inflammatory pathways. Clinical studies (Leyden et al., others) demonstrated measurable increases in skin density, elasticity and thickness after 12 weeks of topical use.

Research associations: collagen and elastin pathways, wound-healing models, and topical dermatology studies of skin density and elasticity. Marketing slogans are not study endpoints.

5. Cognitive & Neurological Support

Key compounds: Semax, Selank, Cerebrolysin, DSIP.

Mechanism: Semax and Selank are Russian-developed neuropeptides that modulate BDNF (brain-derived neurotrophic factor) and GABA systems. Cerebrolysin contains neurotrophic peptide fragments originally studied for stroke and cognitive-decline recovery. DSIP influences sleep architecture at the brainstem level.

Research associations: cognitive and stress-response models, sleep architecture work, and neuroprotection studies in specific recovery settings. Evidence quality varies widely by compound.

6. Immune & Anti-Inflammatory Modulation

Key compounds: Thymosin Alpha-1, LL-37, KPV.

Mechanism: Thymosin Alpha-1 modulates T-cell function and has been studied as an adjunctive therapy in chronic hepatitis and immune-compromised states. KPV (a tripeptide fragment of alpha-MSH) exerts potent anti-inflammatory effects at the cellular level.

Research associations: T-cell and innate-immune signalling, local anti-inflammatory models, and infection-recovery adjunct research in published settings.

Why This Isn’t Snake Oil

Many research peptides are analogues or fragments of endogenous signalling molecules. That familiarity helps explain why receptor pharmacology can be studied in detail. It does not mean every peptide is safe, approved or appropriate for human use.

Research accumulates where receptors, pathways and endpoints can be measured. Licensed medicines and laboratory reagents remain different categories. Downstream effects of receptor binding should be read from the study design, not from marketing copy.

Evidence over slogans. Research-grade manufacturing, purity verification and cold-chain storage are costly for a reason. A documented mechanism and a peer-reviewed dataset still do not convert a research reagent into a medicine. Read the papers. Keep RUO framing.

Frequently Asked Questions

Are the benefits of peptides scientifically backed? Yes. Many peptides have extensive peer-reviewed research behind them. Semaglutide and Tirzepatide have completed Phase III trials. BPC-157 has been studied across dozens of animal and early human trials since the 1990s. GHK-Cu has been validated in gene-expression studies affecting over 4,000 human genes.

What research themes show up most often? Tissue-repair models, metabolic and incretin signalling, growth-hormone axes and sleep, skin and collagen biology, and selected cognitive or immune pathways. Theme popularity is not the same as approval or guaranteed benefit.

Are peptides FDA approved? Several are already approved, including Semaglutide, Tirzepatide, Tesamorelin and Sermorelin. Dozens more are in clinical investigation.

Buy research peptides from New-U Research Compounds

Lab-verified by Janoshik Analytical (RP-HPLC + ESI-MS), sealed vials, discreet tracked worldwide shipping. For laboratory research use only — not for human consumption.

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research

Support

Ways to Pay

Shop by goal

Muscle & IGF Research

Tissue and Cellular Models

Regenerative Research

Cellular Senescence Research

Cognitive Research

Multi-Compound Blends

Shop by compound

CJC-1295 (without DAC)

Shop by region

Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.

Peptide Benefits: What the Research Actually Shows